Correspondence to Dr Rohan S Wijesurendra, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK; rohan.wijesurendra{at}cardiov.ox.ac.uk; Professor Barbara Casadei, Division of ...
Introduction Transcatheter Aortic Valve Implantation (TAVI) is an established treatment option for severe aortic stenosis (AS), with over 5000 procedures performed in the UK in 2019. Given the high ...
Objective Myocardial ischaemia is a leading cause of acute heart failure (AHF). However, optimal revascularisation strategies in AHF are unclear. We aimed to compare two revascularisation strategies, ...
Correspondence to Dr Andreas Martinsson, Department of Cardiology, Sahlgrenska University Hospital, Goteborg 413 45, Sweden; andreas.s.martinsson{at}vgregion.se Objective The optimal medical therapy ...
1 General Office of the Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 National Clinical ...
Correspondence to Dr Jordan D Awerbach, Division of Cardiovascular Medicine, Duke University Medical Center, Durham NC 27710, USA; jordan.awerbach{at}duke.edu ...
Background The timing of onset and associated predictors of late new conduction disturbances (CDs) leading to permanent pacemaker implantation (PPI) following transcatheter aortic valve implantation ...
Correspondence to Dr Ian Ford, University of Glasgow Robertson Centre for Biostatistics, Glasgow G12 8QQ, UK; ian.ford{at}glasgow.ac.uk Methods IRONMAN is a prospective, randomised, open-label, ...
Objective Current guidelines endorse the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF). However, little is known about their safety and efficacy ...
Atrial fibrillation (AF) is characterised by an increased risk of pathological thrombus formation due to a disruption of physiological haemostatic mechanisms that are better understood by reference to ...